| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 4742 |
| 1 | METHOTREXATE | 4184 |
| 2 | CYCLOPHOSPHAMIDE | 3669 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 3669 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3669 |
| 5 | DEXAMETHASONE 1.5 MG | 2390 |
| 6 | DEXAMETHASONE | 2389 |
| 7 | ETOPOSIDE | 2346 |
| 8 | DOXORUBICIN | 2091 |
| 9 | CAPECITABINE | 2011 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOVOTIBEGLOGENE AUTOTEMCEL | 13 | 0.2766 |
| 1 | PALIFERMIN | 56 | 0.1440 |
| 2 | IOBENGUANE I-123 | 14 | 0.1228 |
| 3 | AMIFOSTINE | 92 | 0.1136 |
| 4 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 15 | 0.1000 |
| 5 | FLAVOXATE HYDROCHLORIDE | 10 | 0.0990 |
| 6 | TREOSULFAN | 243 | 0.0880 |
| 7 | THIOTEPA | 830 | 0.0850 |
| 8 | URIDINE TRIACETATE | 12 | 0.0805 |
| 9 | BUSULFAN | 1125 | 0.0706 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 5775 |
| 1 | Alkylating Drug [EPC] | 5469 |
| 2 | Corticosteroid [EPC] | 5125 |
| 3 | Platinum-based Drug [EPC] | 4938 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 4514 |
| 5 | Topoisomerase Inhibitor [EPC] | 2408 |
| 6 | Microtubule Inhibitor [EPC] | 2320 |
| 7 | Kinase Inhibitor [EPC] | 2126 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1957 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1726 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 56 | 0.1440 |
| 1 | Carboxypeptidase [EPC] | 23 | 0.0634 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 83 | 0.0559 |
| 3 | Topoisomerase Inhibitor [EPC] | 2408 | 0.0313 |
| 4 | Actinomycin [EPC] | 69 | 0.0312 |
| 5 | Asparagine-specific Enzyme [EPC] | 357 | 0.0265 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1136 | 0.0240 |
| 7 | Alkylating Drug [EPC] | 5469 | 0.0224 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 5775 | 0.0211 |
| 9 | Anthracycline Topoisomerase Inhibitor [EPC] | 47 | 0.0193 |